IL1B and COVID-19: The expression of these submodules in the blood transcriptome of this small number of COVID-19 patients revealed variation in IL-1β and IL-6 bioactivity over the period of hospitalization, with higher expression seen earlier during hospital admission and a reduction as patients recovered (Figure 5A).